Morgan Stanley analyst Simeon Gutman maintains Target (NYSE:TGT) with a Equal-Weight and lowers the price target from $190 to $155.
EXCLUSIVE: Ocean Biomedical Closes Initial $10M Tranche of $27M Private Placement
Ocean Biomedical Inc (NASDAQ: OCEA) has closed the initial US $10 million tranche of a total anticipated $27 million principal amount of Senior Secured Convertible Notes in a private placement with Ayrton Capital.
The notes will be issued in three tranches:
